ILK and cancer: Examination of 3D models of mammary gland formation revealed that treatment with sEV derived from hypoxic cancer cells resulted in ILK upregulation, increased proliferation, decreased apoptosis and increased EMT markers, and pharmacologic inhibition of ILK suppressed EMT markers, including vimentin and N-cadherin.